BioSpace News Archive

Asking great questions to your interviewer is one of the most important parts of the job interview process. Here are some top interview questions you can learn to ask.

Ahead of being absorbed by Bristol-Myers Squibb, Celgene forged a strategic collaboration with two companies to develop immuno-oncology treatments and cell therapies.

Immunomedics was hoping for a green light from the U.S. Food and Drug Administration for its triple-negative breast cancer treatment, sacituzumab govitecan. However, this morning the company announced that approval will not likely be coming any time soon.

Yesterday, the Endocrinologic and Metabolic Drugs Advisory Committee had a split vote, 8 to 8, on whether the overall benefits of Zynquista (sotagliflozin) outweiged the risk in order to support approval. This sends things back to the agency to make a final decision, which has a target action date of March 22, 2019.

Eli Lilly’s ANNOUNCE Phase III clinical trial of Lartruvo (olaratumab) in advanced or metastatic soft tissue sarcoma failed to meet the primary endpoints of overall survival.

The two companies inked a non-disclosure agreement on December 22, 2018 and amended it a day later. One of the things apparent is that the companies wanted to make a splash at the JPM conference.

Novartis and Oxford will use artificial intelligence and advanced analytics to identify early predictors of inflammatory diseases.

Janssen Pharmaceuticals and Apple have teamed up to determine if a new app for the Apple Watch, which has a built-in electrocardiogram can improve the health of more than 30 million people with atrial fibrillation (AFib), a condition that can lead to stroke and other potentially devastating complications.

Perhaps unsurprisingly, the average cost of developing new drugs is very high. For pharmaceutical companies that are developing multiple drugs, the R&D costs can average around $5 billion.

This year’s Crafoord Prize has been awarded to Sallie Chisholm for the discovery of and research into Prochlorococcus, a very small cyanobacteria of huge importance.